113.26
price down icon0.42%   -0.57
 
loading
前日終値:
$113.83
開ける:
$113.51
24時間の取引高:
2.45M
Relative Volume:
0.55
時価総額:
$196.90B
収益:
$41.22B
当期純損益:
$5.77B
株価収益率:
34.43
EPS:
3.29
ネットキャッシュフロー:
$6.49B
1週間 パフォーマンス:
+0.49%
1か月 パフォーマンス:
-1.95%
6か月 パフォーマンス:
+8.97%
1年 パフォーマンス:
+2.30%
1日の値動き範囲:
Value
$112.97
$114.26
1週間の範囲:
Value
$112.55
$114.26
52週間の値動き範囲:
Value
$99.71
$121.64

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1188)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2024-10-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
113.29 196.90B 41.22B 5.77B 6.49B 3.29
Medical Devices icon
SYK
Stryker Corp
360.60 137.06B 21.97B 3.59B 3.21B 9.33
Medical Devices icon
BSX
Boston Scientific Corp
91.28 133.94B 15.91B 1.79B 1.89B 1.21
Medical Devices icon
MDT
Medtronic Plc
79.92 103.77B 33.00B 4.29B 5.50B 3.27
Medical Devices icon
EW
Edwards Lifesciences Corp
73.35 43.73B 6.60B 4.16B 490.10M 6.93

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
10:35 AM

Pensionfund Sabic Purchases Shares of 25,000 Abbott Laboratories (NYSE:ABT) - MarketBeat

10:35 AM
pulisher
09:39 AM

Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy? - Insider Monkey

09:39 AM
pulisher
04:58 AM

Abbott and 6 other diagnostic stocks to benefit from HMPV virus concerns in India - Trade Brains

04:58 AM
pulisher
Jan 04, 2025

Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt - Yahoo Finance

Jan 04, 2025
pulisher
Jan 03, 2025

Abbott Laboratories stock rises Friday, still underperforms market - MarketWatch

Jan 03, 2025
pulisher
Jan 03, 2025

Abbott Laboratories (NYSE:ABT) Position Raised by Everence Capital Management Inc. - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Big Pharma Partnering Terms and Agreements Analysis Report 2024 with Directory of Over 2,000 Deals Signed Since 2020 - GlobeNewswire Inc.

Jan 03, 2025
pulisher
Jan 03, 2025

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? - Yahoo Finance

Jan 03, 2025
pulisher
Jan 03, 2025

Earnings Preview: What to Expect From Abbott's Report - MSN

Jan 03, 2025
pulisher
Jan 03, 2025

Food Intolerance Products Market Size to Reach $22,654.4 Million by 2031: Nestle, General Mills, Abbott - EIN News

Jan 03, 2025
pulisher
Jan 03, 2025

GAMMA Investing LLC Grows Position in Abbott Laboratories (NYSE:ABT) - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.

Jan 03, 2025
pulisher
Jan 02, 2025

Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch

Jan 02, 2025
pulisher
Jan 02, 2025

PediaSure, Similac Class Action Lawsuit Claims Abbott Lied About Infant Formula Nutritional Value - AboutLawsuits.com

Jan 02, 2025
pulisher
Jan 02, 2025

Abbott Laboratories (NYSE:ABT) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Abbott, Dexcom agree to 10-year truce over diabetes sensor patent litigation - Fierce Biotech

Jan 02, 2025
pulisher
Jan 02, 2025

Abbott, Dexcom settle glucose monitor patent lawsuits - MedTech Dive

Jan 02, 2025
pulisher
Jan 01, 2025

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Jan 01, 2025
pulisher
Jan 01, 2025

Jim Cramer’s Take on Abbott Laboratories (ABT): Bold Predictions for the Future - Insider Monkey

Jan 01, 2025
pulisher
Jan 01, 2025

Abbott Laboratories (NYSE:ABT) Shares Unloaded Sen. Markwayne Mullin - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Dec 31, 2024
pulisher
Dec 31, 2024

Abbott Laboratories (NYSE:ABT) Share Price Passes Above 200-Day Moving AverageShould You Sell? - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Abbott Laboratories (NYSE:ABT) Sees Significant Drop in Short Interest - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Deep Venous Disease Treatment Market Top PlayersAbbott - openPR

Dec 31, 2024
pulisher
Dec 30, 2024

Abbott (ABT) Dips More Than Broader Market: What You Should Know - Yahoo Finance

Dec 30, 2024
pulisher
Dec 30, 2024

Reckitt shares dive as Abbott forced to pay $495m baby formula damages - MSN

Dec 30, 2024
pulisher
Dec 30, 2024

Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch

Dec 30, 2024
pulisher
Dec 30, 2024

How Is The Market Feeling About Abbott Laboratories? - Benzinga

Dec 30, 2024
pulisher
Dec 29, 2024

Abbott Laboratories (NYSE:ABT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Simply Wall St

Dec 29, 2024
pulisher
Dec 28, 2024

Why Is Abbott Laboratories (ABT) Among Diamond Hill Capital’s Top Stock Picks? - Insider Monkey

Dec 28, 2024
pulisher
Dec 27, 2024

Is Abbott Stock Worth Buying at a Discounted P/S Valuation? - MSN

Dec 27, 2024
pulisher
Dec 27, 2024

Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch

Dec 27, 2024
pulisher
Dec 27, 2024

Abbott and DexCom settle glucose monitor patent disputes - HealthLeaders Media

Dec 27, 2024
pulisher
Dec 27, 2024

Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 77% of the company - Yahoo Finance

Dec 27, 2024
pulisher
Dec 26, 2024

February 2025 Options Now Available For Abbott Laboratories (ABT) - Nasdaq

Dec 26, 2024
pulisher
Dec 26, 2024

Abbott Labs Settles Pregnancy Bias Suit With Laid-Off Employee - Bloomberg Law

Dec 26, 2024
pulisher
Dec 25, 2024

Coronary Balloon Products Market Key Players AnalysisAbbott - openPR

Dec 25, 2024
pulisher
Dec 25, 2024

The Art of Valuation: Discovering Abbott Laboratories's Intrinsi - GuruFocus.com

Dec 25, 2024
pulisher
Dec 25, 2024

The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value - Yahoo Finance

Dec 25, 2024
pulisher
Dec 24, 2024

Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance

Dec 24, 2024
pulisher
Dec 24, 2024

Abbott Laboratories stock rises Tuesday, still underperforms market - MarketWatch

Dec 24, 2024
pulisher
Dec 23, 2024

Abbott, DexCom Settle Patent Disputes on Glucose Monitor Tech - Bloomberg Law

Dec 23, 2024
pulisher
Dec 23, 2024

DexCom, Abbott Agree to Settlement in Patent Litigation - The Wall Street Journal

Dec 23, 2024
pulisher
Dec 23, 2024

Abbott Laboratories stock rises Monday, still underperforms market - MarketWatch

Dec 23, 2024
pulisher
Dec 22, 2024

Abbott Laboratories' (NYSE:ABT) investors will be pleased with their respectable 43% return over the last five years - Yahoo Finance

Dec 22, 2024
pulisher
Dec 21, 2024

M&T Bank Corp Sells 65,012 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 21, 2024
pulisher
Dec 21, 2024

Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline - Seeking Alpha

Dec 21, 2024

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices SYK
$361.10
price down icon 0.17%
medical_devices BSX
$91.17
price up icon 0.51%
medical_devices MDT
$80.02
price down icon 1.11%
medical_devices EW
$73.42
price down icon 0.71%
$81.50
price up icon 1.22%
大文字化:     |  ボリューム (24 時間):